Specialty Pharmacy

PTCE, the industry-leading continuing pharmacy education provider, becomes sole provider for association’s 3 major meetings through 2021.

Targeted combination therapy found to improve overall survival with rapid and durable treatment responses in patients with acute myeloid leukemia.

The 11th annual national awards program will take place online this year and recognize 30 exceptional pharmacy professionals in 10 categories

In addition to clinical procedures, some support groups for patients with breast cancer were also canceled as a result of the COVID-19 pandemic.

The researchers found that an ILI aimed at weight loss lowered incidence of obesity-related cancers by 16% in adults with overweight or obesity and T2D

An online survey found that 44% of breast cancer survivors had care delayed during the COVID-19 pandemic.

When telehealth is part of a larger personalized care plan tied specifically to a particular specialty drug, pharmacists can be better positioned to empower their patients.

Following the expansion of Medicaid coverage under the Affordable Care Act, individuals with low income are less likely to be diagnosed with advanced cancer.

The new analysis of the 23-year follow-up results of the trial found that screening women between 40 and 49 years of age led to a substantial and significant 25% reduction in breast cancer mortality in the first 10 years.

The FDA has approved an expansion of the prescribing information for carfilzomib to include its use with daratumumab and dexamethasone for the treatment of relapsed or refractory multiple myeloma.

Because triple-negative breast cancer does not express receptors involved in most breast cancers, the investigative therapy could offer a much-needed option.

Irritable bowel disease, such as ulcerative colitis and Crohn disease, can increase the risk of both cancer and death.

The mortality rates for complex cancer procedures was shown to differ significantly depending on whether the procedure took place at 1-star hospitals or 5-star hospitals.

The American Pharmacists Association, the National Association of Chain Drug Stores, and National Community Pharmacists Association released statements applauding the decision by the HHS to authorize pharmacists to order and administer vaccines for children.

Medical oncologists globally should not discontinue or delay anti-cancer treatment that may potentially impact overall survival during the COVID-19 pandemic.

There is no greater support team available to students than their pharmacy school.

Effective time management can make the difference between a successful pharmacist and an unsuccessful one.

The declaration is in response to a May CDC report, which found a concerning decrease in routine childhood immunizations during the COVID-19 pandemic.

Due to a robust immune system, young women have a lower response rate to immunotherapy.

Extended glucocorticoid use can cause complications such as cardiovascular disorders, infections, and osteoporosis, according to a new study.

Although the majority of survey respondents will continue using telehealth, providers must ensure the safety of their software in order to maintain patient trust.

Mortality rates from non-small cell lung cancer have significantly declined in the United States in recent years.

Four new subtypes of cells within triple-negative breast cancer have been uncovered, containing promising new therapeutic targets for the disease.

Fingolimod (Gilenya), which is approved by the FDA to treat multiple sclerosis flare-ups, may also block HIV and reduce the latent reservoir.

Cancer survivors’ lean body mass found to be lower than the general population, which was connected with prior abdominal or pelvic radiation.

Vitolarsen is the second FDA-approved targeted treatment for patients with Duchenne muscular dystrophy who have a confirmed mutation of the gene that is amenable to exon 53 skipping.

Like so many other conferences and events, ASCO transitioned to an online format because of the coronavirus disease 2019 (COVID-19) outbreak.

Study shows significant genomic differences between tumors caused by different strains of human papillomavirus.

Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,

The combination of sintilimab, pemetrexed, and a platinum-based chemotherapy has shown promise for nonsquamous non-small cell lung cancer.